Essential Hypertension
Conditions
Keywords
Dipper, Non-dipper, Chronopharmacology
Brief summary
Rationale: The nocturnal blood pressure mean is an independent and stronger predictor of cardiovascular disease (CVD) risk than either daytime office, awake or 24hour mean blood pressure. In general, when nocturnal blood pressure does not decline CVD risk is higher, usually referred to as dippers versus non-dippers. Evening administration of treatment might lower nocturnal blood pressure more effectively than morning administration, which is most commonly advised. The main hypothesis of this study is that evening administration of antihypertensive medication might resume the dipping pattern in non-dippers and as a consequence might reduce CVD risk more than morning administration. Primary objective (in short): -to prove that evening administration of enalapril/hydrochlorothiazide in non-dippers can resume a dipping blood pressure pattern in non-dippers Study design: A double-blind placebo-controlled cross-over study Each person will use for one period of six weeks enalapril/hydrochlorothiazide in the morning and placebo in the evening, and one period of six weeks the other way around
Interventions
DRUGEnalapril/hydrochlorothiazide
The intervention implies that morning and evening administration of enalapril/hydrochlorothiazide will be compared
DRUGPlacebo
Sponsors
ZonMw: The Netherlands Organisation for Health Research and Development
Erasmus Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Essential hypertension * Stable blood pressure on treatment with Angiotensin Converting Enzyme Inhibitor (ACEI) or Angiotensin II Receptor Blocker (ARB) and hydrochlorothiazide * Age between 18 and 85 years * WHO performance status 0-1 * Available for a time period of 15 weeks * Written informed consent * Dippers: Nocturnal blood pressure fall of 10-20% of daytime values.20 * Non-dippers: -Nocturnal blood pressure fall of \<10% of daytime values
Exclusion criteria
* secondary cause of hypertension * use of ARB because of intolerability (e.g. dry cough) of ACEI * nocturnal blood pressure fall of \>20% or rise * renal insufficiency (GFR\<60 ml/min) * shift work * pregnancy or wish to get pregnant * use of other antihypertensive medication than ACEI, ARB, hydrochlorothiazide or a calcium channel blocker * use of sleeping medication
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average nocturnal blood pressure, percentage dipping and nadir of nocturnal blood pressure | 24 hours | At the end of each treatment period of six weeks, a 24 hour ambulatory blood pressure measurement will be performed |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of nocturnal diastolic blood pressure measurements below 65 mm hg | 24 hours | One safety issue on evening administration of antihypertensive treatment is that blood pressure might get too low. We will assess this especially in the dippers. |
| Urine: Sodium, potassium, protein, melatonin, creatinin | Two times within 24 hours at the end of six weeks of treatment according to one of the two regimes | Excretion of sodium, potassium, protein and melatonin depend on the circadian clock. Therefore, differences between morning and evening administration of antihypertensive medication are tested |
| Plasma: enalapril, cortisol, melatonin, aldosterone, ACE activity, gene expression of clock genes | Moring of 24 hour blood pressure measurement after six weeks of treatment according to a certain regime | — |
Countries
Netherlands
Contacts
Primary ContactJorie Versmissen, MD, PhD
Outcome results
None listed